18 results
253G2
PHBI
Pharmagreen Biotech Inc.
4 Oct 21
Offering circular supplement
10:46am
such as those imposed by Sarbanes-Oxley Act of 2002. Our senior management has never had sole responsibility for managing a publicly traded company … of this uncertainty.
Basis for Opinion
These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express
CORRESP
PHBI
Pharmagreen Biotech Inc.
23 Sep 21
Correspondence with SEC
12:00am
pursuant to delegated authority, to declare the filing qualified does not relieve the Company from its full responsibility for the adequacy and accuracy
8-K
EX-99.1
hshkz20nb0zii0qwlz
12 Aug 20
Bankruptcy or Receivership
3:38pm
8-K
EX-99.3
ibo7u8 acqh884gugm2s
4 Mar 20
Securities Purchase Agreement
12:00am
8-K
EX-10.3
awm2 349vuyg
8 Nov 19
Entry into a Material Definitive Agreement
4:48pm
CORRESP
2s5f2i
9 Jul 19
Correspondence with SEC
12:00am
10-K
p9zx2n6b
13 Aug 09
Annual report
12:00am
8-K
EX-10.2
1eg0021syhqxummm5ro
12 Jan 09
Entry into a Material Definitive Agreement
12:00am
- Prev
- 1
- Next